West Pharmaceutical Services Announces Third Quarter 20...(CONSOLIDATED STATEMENTS OF INCOME ...),Health

(UNAUDITED)

(in millions, except per share data)

Three Months Ended Nine Months Ended

Sept. 30, Sept. 30, Sept. 30, Sept. 30,

2007 2006 2007 2006

Net sales $242.7 100% $218.4 100% $764.0 100% $681.4 100%

Cost of goods

sold 178.4 74 158.9 73 542.7 71 483.1 71

Gross profit 64.3 26 59.5 27 221.3 29 198.3 29

Research and

development 4.1 2 2.9 1 11.5 2 8.0 1

Selling, general

and administrative

expenses 37.7 15 34.9 16 112.8 15 106.1 15

Other expense, net 9.6 4 2.0 1 9.7 1 4.2 1

Operating profit 12.9 5 19.7 9 87.3 11 80.0 12

Loss on debt

extinguishment - - - - - - 5.9 1

Interest expense,

net 2.0 - 2.7 1 5.9 1 8.5 1

Income before

income taxes

and minority

interests 10.9 5 17.0 8 81.4 10 65.6 10

Provision for

income taxes (0.8) - 4.9 2 17.4 2 19.4 3

Minority interests 0.1 - 0.1 - 0.3 - 0.3 -

Income from

consolidated

operations 11.6 5% 12.0 6% 63.7 8% 45.9 7%

Equity in net

income of

affiliated

companies 0.6 (0.2) 1.5 0.9

Income from

continuing

operations 12.2 11.8 65.2 46.8

Discontinued

operations,

net of tax - 1.5 (0.5) 5.3

Net income $12.2 $13.3 $64.7 $52.1

Net income

p
'/>"/>